🇺🇸 FDA
Patent

US 7348314

Compositions and methods for inhibiting viral replication

granted A61PA61P35/00

Quick answer

US patent 7348314 (Compositions and methods for inhibiting viral replication) held by Alnylam Europe AG expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Europe AG
Grant date
Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P35/00